Dicerna Pharmaceuticals is covered by the following analysts.
|B. Riley FBR||Mayank Mamtani|
|Evercore ISI||Umer Raffat|
|Goldman Sachs||Madhu Kumar|
|H.C. Wainwright & Co.||Ed Arce|
|RBC Capital Markets||Luca Issi|
|SVB Leerink||Mani Foroohar, M.D.|
|Truist Securities||Robyn Karnauskas|
Dicerna Pharmaceuticals is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Dicerna Pharmaceuticals's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Dicerna Pharmaceuticals or its management. Dicerna Pharmaceuticals does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.